{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T08:18:47Z","timestamp":1773130727252,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T00:00:00Z","timestamp":1531267200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004919","name":"King Abdulaziz City for Science and Technology","doi-asserted-by":"publisher","award":["AT-32-44 (P-L-10-0051) and 13-MED1765-20"],"award-info":[{"award-number":["AT-32-44 (P-L-10-0051) and 13-MED1765-20"]}],"id":[{"id":"10.13039\/501100004919","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12881-018-0629-2","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T13:58:56Z","timestamp":1531317536000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Phenotype heterogeneity of congenital adrenal hyperplasia due to genetic mosaicism and concomitant nephrogenic diabetes insipidus in a sibling"],"prefix":"10.1186","volume":"19","author":[{"given":"Y\u0131lmaz","family":"Kor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minjing","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roua A.","family":"Al-Rijjal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Monies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian F.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6999-0191","authenticated-orcid":false,"given":"Yufei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,11]]},"reference":[{"issue":"2","key":"629_CR1","first-page":"241","volume":"78","author":"WL Miller","year":"1994","unstructured":"Miller WL. Clinical review 54: genetics, diagnosis, and management of 21-hydroxylase deficiency. J Clin Endocrinol Metab. 1994;78(2):241\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"22","key":"629_CR2","doi-asserted-by":"publisher","first-page":"12790","DOI":"10.1073\/pnas.96.22.12790","volume":"96","author":"MI New","year":"1999","unstructured":"New MI, Wilson RC. Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess. Proc Natl Acad Sci U S A. 1999;96(22):12790\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"629_CR3","first-page":"245","volume":"21","author":"PC White","year":"2000","unstructured":"White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev. 2000;21(3):245\u201391.","journal-title":"Endocr Rev"},{"issue":"2","key":"629_CR4","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ecl.2017.01.008","volume":"46","author":"F Hannah-Shmouni","year":"2017","unstructured":"Hannah-Shmouni F, Chen W, Merke DP. Genetics of congenital adrenal hyperplasia. Endocrinol Metab Clin N Am. 2017;46(2):435\u201358. https:\/\/doi.org\/10.1016\/j.ecl.2017.1001.1008 . Epub 2017 Mar 1011","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"6 Pt 1","key":"629_CR5","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/clinchem\/48.6.818","volume":"48","author":"N Krone","year":"2002","unstructured":"Krone N, Braun A, Weinert S, Peter M, Roscher AA, Partsch CJ, Sippell WG. Multiplex minisequencing of the 21-hydroxylase gene as a rapid strategy to confirm congenital adrenal hyperplasia. Clin Chem. 2002;48(6 Pt 1):818\u201325.","journal-title":"Clin Chem"},{"issue":"11","key":"629_CR6","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1210\/jc.2006-1645","volume":"91","author":"MI New","year":"2006","unstructured":"New MI. Extensive clinical experience: nonclassical 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2006;91(11):4205\u201314. Epub 2006 Aug 4215","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"629_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.beem.2008.10.014","volume":"23","author":"N Krone","year":"2009","unstructured":"Krone N, Arlt W. Genetics of congenital adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab. 2009;23(2):181\u201392. https:\/\/doi.org\/10.1016\/j.beem.2008.1010.1014 .","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"7","key":"629_CR8","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1073\/pnas.1300057110","volume":"110","author":"MI New","year":"2013","unstructured":"New MI, Abraham M, Gonzalez B, Dumic M, Razzaghy-Azar M, Chitayat D, Sun L, Zaidi M, Wilson RC, Yuen T. Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Proc Natl Acad Sci U S A. 2013;110(7):2611\u20136. https:\/\/doi.org\/10.1073\/pnas.1300057110 . Epub 1300052013 Jan 1300057128","journal-title":"Proc Natl Acad Sci U S A"},{"key":"629_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.steroids.2016.01.007","volume":"108","author":"R Wang","year":"2016","unstructured":"Wang R, Yu Y, Ye J, Han L, Qiu W, Zhang H, Liang L, Gong Z, Wang L, Gu X. 21-hydroxylase deficiency-induced congenital adrenal hyperplasia in 230 Chinese patients: Genotype-phenotype correlation and identification of nine novel mutations. Steroids. 2016;108:47\u201355. https:\/\/doi.org\/10.1016\/j.Steroids2016.1001.1007 . Epub 2016 Jan 1021","journal-title":"Steroids"},{"issue":"2","key":"629_CR10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1053\/j.ackd.2006.01.006","volume":"13","author":"DG Bichet","year":"2006","unstructured":"Bichet DG. Nephrogenic diabetes insipidus. Adv Chronic Kidney Dis. 2006;13(2):96\u2013104.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"3","key":"629_CR11","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s10157-012-0726-z","volume":"17","author":"S Sasaki","year":"2013","unstructured":"Sasaki S, Chiga M, Kikuchi E, Rai T, Uchida S. Hereditary nephrogenic diabetes insipidus in Japanese patients: analysis of 78 families and report of 22 new mutations in AVPR2 and AQP2. Clin Exp Nephrol. 2013;17(3):338\u201344. https:\/\/doi.org\/10.1007\/s10157%2D10012%2D10726%2Dz . Epub 12012 Nov 10114","journal-title":"Clin Exp Nephrol"},{"issue":"10","key":"629_CR12","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s00431-015-2534-4","volume":"174","author":"A Garcia Castano","year":"2015","unstructured":"Garcia Castano A, Perez de Nanclares G, Madariaga L, Aguirre M, Chocron S, Madrid A, Lafita Tejedor FJ, Gil Campos M, Sanchez Del Pozo J, Ruiz Cano R, et al. Novel mutations associated with nephrogenic diabetes insipidus. A clinical-genetic study. Eur J Pediatr. 2015;174(10):1373\u201385. https:\/\/doi.org\/10.1007\/s00431%2D00015%2D02534%2D00434 . Epub 02015 Apr 00423","journal-title":"Eur J Pediatr"},{"issue":"1","key":"629_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1172\/JCI2605","volume":"102","author":"SM Mulders","year":"1998","unstructured":"Mulders SM, Bichet DG, Rijss JP, Kamsteeg EJ, Arthus MF, Lonergan M, Fujiwara M, Morgan K, Leijendekker R, van der Sluijs P, et al. An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex. J Clin Invest. 1998;102(1):57\u201366.","journal-title":"J Clin Invest"},{"issue":"21\u201322","key":"629_CR14","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1016\/j.cca.2011.06.033","volume":"412","author":"YC Lin","year":"2011","unstructured":"Lin YC, Lin YC, Liu TC, Chang JG, Lee HH. High-resolution melting curve (HRM) analysis to establish CYP21A2 mutations converted from the CYP21A1P in congenital adrenal hyperplasia. Clin Chim Acta. 2011;412(21\u201322):1918\u201323. https:\/\/doi.org\/10.1016\/j.cca.2011.1906.1033 . Epub 2011 Jul 1916","journal-title":"Clin Chim Acta"},{"issue":"4","key":"629_CR15","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1520\/JFS15445J","volume":"47","author":"BE Krenke","year":"2002","unstructured":"Krenke BE, Tereba A, Anderson SJ, Buel E, Culhane S, Finis CJ, Tomsey CS, Zachetti JM, Masibay A, Rabbach DR, et al. Validation of a 16-locus fluorescent multiplex system. J Forensic Sci. 2002;47(4):773\u201385.","journal-title":"J Forensic Sci"},{"issue":"2","key":"629_CR16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1681\/ASN.V82242","volume":"8","author":"SM Mulders","year":"1997","unstructured":"Mulders SM, Knoers NV, Van Lieburg AF, Monnens LA, Leumann E, Wuhl E, Schober E, Rijss JP, Van Os CH, Deen PM. New mutations in the AQP2 gene in nephrogenic diabetes insipidus resulting in functional but misrouted water channels. J Am Soc Nephrol. 1997;8(2):242\u20138.","journal-title":"J Am Soc Nephrol"},{"issue":"26","key":"629_CR17","doi-asserted-by":"publisher","first-page":"10767","DOI":"10.1074\/jbc.M117.792465","volume":"292","author":"C Wang","year":"2017","unstructured":"Wang C, Pallan PS, Zhang W, Lei L, Yoshimoto FK, Waterman MR, Egli M, Guengerich FP. Functional analysis of human cytochrome P450 21A2 variants involved in congenital adrenal hyperplasia. J Biol Chem. 2017;292(26):10767\u201378. https:\/\/doi.org\/10.11074\/jbc.M10117.792465 . Epub 792017 May 792424","journal-title":"J Biol Chem"},{"issue":"8","key":"629_CR18","first-page":"1211","volume":"6","author":"D Owerbach","year":"1992","unstructured":"Owerbach D, Sherman L, Ballard AL, Azziz R. Pro-453 to Ser mutation in CYP21 is associated with nonclassic steroid 21-hydroxylase deficiency. Mol Endocrinol. 1992;6(8):1211\u20135.","journal-title":"Mol Endocrinol"},{"key":"629_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/nyas.12864","volume":"1364","author":"A Khattab","year":"2016","unstructured":"Khattab A, Yuen T, Al-Malki S, Yau M, Kazmi D, Sun L, Harbison M, Haider S, Zaidi M, New MI. A rare CYP21A2 mutation in a congenital adrenal hyperplasia kindred displaying genotype-phenotype nonconcordance. Ann N Y Acad Sci. 2016;1364:5\u201310. https:\/\/doi.org\/10.1111\/nyas.12864 . Epub 12015 Aug 12820","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"629_CR20","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1089\/thy.2013.0610","volume":"24","author":"M Zou","year":"2014","unstructured":"Zou M, Baitei EY, Alzahrani AS, BinHumaid FS, Alkhafaji D, Al-Rijjal RA, Meyer BF, Shi Y. Concomitant RAS, RET\/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma. Thyroid. 2014;24(8):1256\u201366. https:\/\/doi.org\/10.1089\/thy.2013.0610 . Epub 2014 Jun 1210","journal-title":"Thyroid"},{"issue":"6","key":"629_CR21","doi-asserted-by":"publisher","first-page":"F1318","DOI":"10.1152\/ajprenal.00485.2016","volume":"311","author":"HJ Jung","year":"2016","unstructured":"Jung HJ, Kwon TH. Molecular mechanisms regulating aquaporin-2 in kidney collecting duct. Am J Physiol Renal Physiol. 2016;311(6):F1318\u201328. https:\/\/doi.org\/10.1152\/ajprenal.00485.02016 . Epub 02016 Oct 00419","journal-title":"Am J Physiol Renal Physiol"},{"issue":"12","key":"629_CR22","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1681\/ASN.V8121951","volume":"8","author":"DG Bichet","year":"1997","unstructured":"Bichet DG, Oksche A, Rosenthal W. Congenital nephrogenic diabetes insipidus. J Am Soc Nephrol. 1997;8(12):1951\u20138.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"629_CR23","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.beem.2016.02.010","volume":"30","author":"DG Bichet","year":"2016","unstructured":"Bichet DG, Bockenhauer D. Genetic forms of nephrogenic diabetes insipidus (NDI): vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant). Best Pract Res Clin Endocrinol Metab. 2016;30(2):263\u201376. https:\/\/doi.org\/10.1016\/j.beem.2016.1002.1010 . Epub 2016 Mar 1012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"10","key":"629_CR24","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1681\/ASN.2005040371","volume":"16","author":"TM Fujiwara","year":"2005","unstructured":"Fujiwara TM, Bichet DG. Molecular biology of hereditary diabetes insipidus. J Am Soc Nephrol. 2005;16(10):2836\u201346. Epub 2005 Aug 2810","journal-title":"J Am Soc Nephrol"},{"issue":"5 Pt 2","key":"629_CR25","first-page":"F734","volume":"277","author":"I Shinbo","year":"1999","unstructured":"Shinbo I, Fushimi K, Kasahara M, Yamauchi K, Sasaki S, Marumo F. Functional analysis of aquaporin-2 mutants associated with nephrogenic diabetes insipidus by yeast expression. Am J Phys. 1999;277(5 Pt 2):F734\u201341.","journal-title":"Am J Phys"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-018-0629-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12881-018-0629-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-018-0629-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T06:55:09Z","timestamp":1661583309000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/s12881-018-0629-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,11]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["629"],"URL":"https:\/\/doi.org\/10.1186\/s12881-018-0629-2","relation":{},"ISSN":["1471-2350"],"issn-type":[{"value":"1471-2350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,11]]},"assertion":[{"value":"16 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed consent to participate in the study was obtained from participants or their parent in the case of children under 16. The Ethics Committee of King Faisal Specialist Hospital and Research Centre approved the study (RAC # 2100005).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent was obtained from parents to publish patient data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"115"}}